Verification of Newly FDA-Approved Kappa and Lambda Free Light Chain Assays on a Previously Untested Platform
Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma | Leukemia
Freelite® & Hevylite®
Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library
Serum free light chains in clinical laboratory diagnostics - ScienceDirect
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Binding Site | What is Freelite
International Clinical Product Listing
Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library
Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia - Pratt - 2009 - British Journal of Haematology - Wiley Online Library
Serum free light chain assays (Freelite®) are recommended by the NCCN Clinical Practice Guidelines in Oncology and the Internat
PDF) Free Kappa and Lambda Light Chains in Plasma Cell Dyscrasias